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Abstract
Capsular contraction following implantation of breast prostheses occurs in 2–33% of patients
undergoing breast augmentation. This condition can be debilitating for patients, and often requires
revisional surgery. The aetiology of capsular contraction is unclear, but may be due to infection,
haematoma or foreign body-type reactions.
Methylene blue dye is a substance known to cause localised tissue inflammation, and is often used
during breast cancer surgery to allow identification of the sentinel lymph node. We report a case
of Baker Grade 4 capsular contraction necessitating revisional surgery, occurring in a patient who
underwent immediate breast reconstruction during surgery for breast cancer. Methylene blue dye
was used to locate the sentinel nodes during the original surgery, and was found to have heavily
discoloured the prosthesis at subsequent revisional surgery. Capsular contraction may have been
caused in part by a localised tissue reaction initiated by, or involving the dye.
Introduction
Immediate breast reconstruction during surgery for breast
cancer is gaining in popularity. An implantable tissue
expander is often used during the procedure. A late com-
plication with the implantation of breast prostheses, espe-
cially those filled with silicone, is the onset of fibrous
capsular contraction [1,2]. This can be debilitating for
patients, and often necessitates revisional surgery. Whilst
the aetiology of capsular contraction is unclear, its patho-
genesis clearly involves a localised tissue reaction [3,4].
We report a case of severe capsular contraction in associa-
tion with intense methylene blue dye staining of a saline-
filled prosthesis. This occurred following immediate
reconstructive surgery for breast cancer, in which methyl-
ene blue dye was used to identify the sentinel lymph
node. The known tissue reactive properties of methylene
blue dye [4-6] suggest that it may have been implicated in
the pathogenesis of the fibrous contracture.
Case Report
A 58-year-old woman presented to the Breast Unit with a
1.7 cm-sized screen-detected carcinoma of the left breast,
located lateral to the nipple. After confirmation of the
diagnosis by fine-needle aspiration cytology (FNAC), the
patient underwent immediate breast reconstructive
surgery.
Subdermal periareolar injection of 1.5 ml of 1 percent
methylene blue dye was performed five minutes prior to
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definitive surgery, to facilitate identification of the senti-
nel lymph node. Two blue lymph nodes were subse-
quently found during the course of axillary dissection,
and removed. A skin-sparing mastectomy and immediate
reconstruction were then performed, using a Becker™
saline-filled tissue expander implant.
The postoperative course was uneventful, and the patient
was discharged from hospital after 4 days.
Seven days after surgery, the patient returned to the Breast
Unit with a seroma surrounding the prosthesis. This was
aspirated twice under ultrasound guidance, revealing
serous fluid content only. An ultrasound scan at eight
weeks showed the fluid collection had completely
resolved.
Nine months later, the patient developed a Baker Grade 4
capsular contracture [7], and consented for revisional
surgery.
At surgery, a thick fibrous inflammatory capsule was
found surrounding the implant, and on removal the pros-
thesis was noted to have an intense blue discolouration
(Figure 1).
The patient was discharged five days after surgery, and was
well at last follow-up.
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Conclusion
Methylene blue dye is used in a variety of operative proce-
dures, including breast surgery, to allow delineation of
anatomical structures [4,8,9].
Use of the dye however, has been associated with a
number of local and systemic complications. These
include localised eruptions and rashes [4,6], subcutane-
ous tissue necrosis and abscess formation [8], methaemo-
globinaemia [10], and anaphylaxis [11].
The tissue reaction to methylene blue dye is a foreign
body – type reaction characterised by eosinophilic infiltra-
tion, fibrinoid necrosis with ischaemic ulceration [4].
Fibrous capsule formation occurs around any implanted
device as part of normal healing. After implantation of a
breast prosthesis this process can lead to deleterious clin-
ical changes, ranging from imperceptible deformation of
the implant, to significant distortion and firmness [7]. The
latter changes are often accompanied by tenderness and
discomfort for the patient, necessitating revisional sur-
gery. Recent studies have estimated an incidence of
between 2% to 33% of capsular contraction in patients
undergoing breast augmentation with various types of
prosthesis [1,2]. The precise aetiology of capsular contrac-
tion is unclear, but may be related to factors such as infec-
tion, excessive bleeding at the time of surgery, or foreign
body reactions [3].
Although subareolar intradermal injection of methylene
blue dye to aid sentinel node localisation is described as a
generally safe procedure [12], acute adverse events caused
by the dye during breast surgery have been reported
[11,13].
In this patient, a Grade 4 capsular contracture occurred
some time after surgery in the presence of an implant
intensely discoloured by the blue dye.
Whilst absolute causality cannot be proven, the presence
of inflammation around the implant, together with the
known tissue-reactive properties of methylene blue dye
suggest that this substance may have been involved in a
local tissue reaction which facilitated the development of
the condition.
Use of methylene blue dye to localise sentinel nodes dur-
ing immediate breast reconstructive surgery must there-
fore be considered as a factor which may increase the risk
of subsequent capsular contraction.
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